Discovery and optimization of a series of carbazole ureas as NPY5 antagonists for the treatment of obesity.
Saved in:
| Title: | Discovery and optimization of a series of carbazole ureas as NPY5 antagonists for the treatment of obesity. |
|---|---|
| Authors: | Block MH; AstraZeneca, Alderley Park, Macclesfield, Cheshire SK10 4TG, United Kingdom. Michael.Block@Astrazeneca.com, Boyer S, Brailsford W, Brittain DR, Carroll D, Chapman S, Clarke DS, Donald CS, Foote KM, Godfrey L, Ladner A, Marsham PR, Masters DJ, Mee CD, O'Donovan MR, Pease JE, Pickup AG, Rayner JW, Roberts A, Schofield P, Suleman A, Turnbull AV |
| Source: | Journal of medicinal chemistry [J Med Chem] 2002 Aug 01; Vol. 45 (16), pp. 3509-23. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Chemical Society Country of Publication: United States NLM ID: 9716531 Publication Model: Print Cited Medium: Print ISSN: 0022-2623 (Print) Linking ISSN: 00222623 NLM ISO Abbreviation: J Med Chem Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
